Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mouse eggs fixed with paraformaldehyde were incubated with various exoglycosidases and their sperm-binding activities were examined. The number of sperm bound per egg was increased by sialidase treatment and decreased by
beta-galactosidase
treatment. No prominent reduction of sperm-binding was observed after alpha-galactosidase treatment. Mouse sperm also bound to asialofetuin-coupled agarose beads but not to fetuin-coupled beads. The sperm-binding was abolished when asialofetuin-gel was treated with
beta-galactosidase
specific to the
beta 1
-->4 linkage or N-Glycanase. Furthermore asialofetuin, but not
beta-galactosidase
-treated asialofetuin, competitively inhibited the binding of sperm to the zona pellucida of live eggs. These results suggest that mouse sperm recognize beta-galactose residues of the zona pellucida at the initial stage of the binding.
...
PMID:Binding of mouse sperm to beta-galactose residues on egg zona pellucida and asialofetuin-coupled beads. 929 59
A novel
beta-galactosidase
(beta-gal) gene was cloned from Bacillus circulans ATCC 31382. The coding region was 1,758 bp and encoded a polypeptide of 586 amino acids with a deduced molecular mass of 66,888. Active staining for beta-gal showed that B. circulans ATCC 31382 produced three beta-gal isozymes. Two of these were detected in Biolacta N5 (Daiwakasei Co.), but the product of this novel gene corresponded to the one not contained in Biolacta N5. The novel beta-gal showed the highest amino acid sequence identity (43.3%) with a
beta 1
-->3 > 1-->4 galactosidase from Xanthomonas manihotis and was also highly similar to beta-gals from animals, plants, and fungi. This suggests an evolutionary relationship between this novel gene and those of eukaryotic origins. One of the two B. circulans beta-gals, the nucleotide sequences of which are available in the GenBank, was 20% identical to the novel beta-gal. Other bacterial beta-gals showed little or no similarity. We propose that this novel beta-gal be called B. circulans beta-gal-3, and the gene be called bgaC.
...
PMID:Cloning and characterization of the gene encoding a novel beta-galactosidase from Bacillus circulans. 930 Nov 6
Non-acid glycosphingolipids were isolated from small intestinal epithelial cells of a single blood group A pig. One very predominant blood group compound was obtained chemically pure upon HPLC fractionation. It was characterized by mass spectrometry and 1H NMR spectroscopy to be the type 1 chain blood group A hexaglycosylceramide. Support for the presence of minute amounts of additional A glycolipids was obtained by mass spectrometry and immunostaining of TLC plates with anti-A antibodies specific for A type 2 chain, A type 3 and 4 chain, and the ALe(b) determinant. Among precursor chains, globoside (type 4) and lactotetraosylceramide (type 1) were immunologically identified, whereas no neolactotetraosylceramide (type 2) and gangliotetraosylceramide reactivities were detected. We addressed the question whether the predominant expression of type 1 chain based A glycolipids reflects a restricted glycolipid precursor chain specificity of the alpha 1-2 fucosyl- and/or the alpha 1-3 N-acetylgalactosaminyltransferases, or if the biosynthesis of the precursor chains themselves is regulated. All precursor core saccharides, lacto- (type 1), neolacto-(type 2), and gangliotetraosylceramide as well as globopentaosylceramide (type 4), could serve as acceptors for fucose in vitro when a crude microsomal fraction obtained from mechanically released, porcine intestinal epithelial cells was used as an enzyme source. Under the same conditions an N-acetylgalactosamine residue could be transferred to the blood group H structures based on these core saccharide chains. Lactotriaosylceramide, but not gangliotriaosylceramide, could serve as an acceptor for UDP-galactose. When the product was digested with
beta-galactosidase
(
EC 3.2.1.23
) from S.pneumoniae, under conditions where it specifically cleaves Gal
beta 1
-4 residues, approximately 40% of the radioactivity was cleaved off, indicating that a substantial amount of neolactotetraosylceramide was made in vitro, as opposed to the predominance of lactotetraosylceramide-based structures found in vivo.
...
PMID:Biochemical and enzymatic characterization of blood group ABH and related histo-blood group glycosphingolipids in the epithelial cells of porcine small intestine. 936 37
The murine LAMB1 gene encoding laminin
beta 1
is expressed in the developing male and female gonads and mesonephros. To identify the cis-acting elements regulating the expression of LAMB1, murine transgenic lines were generated by fusing regions of the LAMB1 gene to the Eschericia coli lacZ gene. The p3.9LAM beta gal construct contained approximately 4 kb of 5' flanking sequence and directed
beta-galactosidase
expression in many different organs including the kidney, mammary gland, and the male and female genital systems, the focus of this report. In male embryos, between gestational ages E 14.5 and birth
beta-galactosidase
was transiently expressed in the prospermatogonia cells of the testis and in the differentiating epithelial cells in the ductus deferens, ductus epididymis, and seminal vesicles. In female embryos,
beta-galactosidase
was not detected in the ovary until about 1 week after birth; at this time,
beta-galactosidase
was expressed by oocytes of primary and secondary follicles. In contrast, transgenic mice carrying the first 0.7 kb of LAMB1 fused to the lacZ gene expressed
beta-galactosidase
only in the prospermatogonia cells of the testis. Thus, the cis-acting element(s) necessary for the expression of the LAMB1 gene in prospermatogonia cells are located in the first 0.7 kb of LAMB1 5' flanking sequence; element(s) required for expression of the LAMB1 gene in oocytes and epithelial cells of the mesonephric ducts, mesonephric tubules, the ductus deferens, ductus epididymis, and seminal vesicles are located with 4 kb 5' of the transcription initiation site.
...
PMID:Sequences 5' of the basement membrane laminin beta 1 chain gene (LAMB1) direct the expression of beta-galactosidase during development of the mouse testis and ovary. 944 7
We have used the analytical system based on surface plasmon resonance to monitor the interaction between Amaranthus hypochondriacus var. Mexico lectin and four different fetuins; fetuin, asialofetuin, agalactofetuin, and agalactosaminofetuin. Agalactofetuin and agalactosaminofetuin were prepared by enzymic digestion of asialofetuin using jack bean
beta-galactosidase
or endo-alpha-N-acetylgalactosaminidase from Diplococcus pneumoniae. Ligands were immobilized onto a sensor surface via amide linkages. The lectin interacted most strongly with asialofetuin, but not with agalactosaminofetuin. The binding of the lectin to asialofetuin was inhibited by N-acetylgalactosamine or Gal
beta 1
-->3GalNAc in a dose-dependent manner.
...
PMID:A surface plasmon resonance assay for the binding of Amaranthus hypochondriacus var. Mexico lectin to glycoprotein. 950 65
A low-copy-number vector designated pTCV-lac has been constructed to provide a convenient system to analyze regulatory elements in Gram-positive bacteria. The main components of this vector are: (i) the origins of replication of pACYC184 and of the broad-host-range enterococcal plasmid pAM
beta 1
, (ii) erythromycin- and kanamycin-resistance-encoding genes for selection in Gram-negative and Gram-positive bacteria, (iii) the transfer origin of the IncP plasmid RK2, and (iv) a promoterless
beta-galactosidase
-encoding lacZ gene with a Gram-positive ribosome binding site. This 12 kb plasmid is present in Gram-positive hosts in three to five copies per chromosome equivalent and contains three unique cloning sites (EcoRI, SmaI, BamHI) for cloning of DNA inserts upstream of the lacZ gene. Plasmid pTCV-lac and derivatives carrying different promoter fragments have been transferred by conjugation from an Escherichia coli IncP mobilizing donor strain to Bacillus subtilis, Listeria monocytogenes, Enterococcus faecalis, and Streptococcus agalactiae. These plasmids were structurally stable in these hosts and the corresponding promoter activities, quantitated by the determination of the
beta-galactosidase
specific activities, were found to cover at least a 100-fold range in
beta-galactosidase
values. These results indicate that pTCV-lac should be useful for analysis of gene regulation in a wide range of Gram-positive bacteria.
...
PMID:A broad-host-range mobilizable shuttle vector for the construction of transcriptional fusions to beta-galactosidase in gram-positive bacteria. 951 64
The synthetic glycosides, p-nitrophenyl- and o-nitrophenyl-2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-alpha- D-galactopyranosides, were found to be effective chromogenic substrates for an endo-alpha-N-acetyl-D-galactosaminidase. We did not experience any problems when these substrates were used for the screening of column fractions during the purification of the endoenzyme from Diplococcus pneumoniae culture filtrates. However, it should be pointed out that a combination of exo-
beta-galactosidase
, capable of cleaving
beta 1
-->3 linkages, and an exo-alpha-N-acetyl galactosaminidase would also liberate nitrophenol from the above substrates. The enzyme had no action on several other synthetic glycosides tested indicating the strict specificity of this enzyme for the disaccharide Gal beta-->GalNAc linked via an alpha-linkage to the aglycone. The enzyme was inactive when the aglycone was methanol but shows activity against the glycosides of phenol, nitrophenols, serine, and threonine. The use of p-nitrophenyl-2-acetamido-2-deoxy-3-O-beta -D-galactopyranosyl-beta-D-galactopyranoside, which is a competitive inhibitor of the endoenzyme, as an affinity ligand for the purification of the enzyme is described.
...
PMID:Action of endo-alpha-N-acetyl-D-galactosaminidase on synthetic glycosides including chromogenic substrates. 976 98
In the present work, the combination of chemical and enzymatic methods to obtain neoglycoproteins is described. Three bovine serum albumin (BSA)-conjugates, BSA-[GalNAc alpha-], BSA-[Gal(
beta 1
-3)GalNAc(alpha-], and BSA-[Neu5Ac(alpha 2-3)Gal(
beta 1
-3)GalNAc(alpha-], were prepared. alpha GalNAc derivatives were galactosylated employing crude
beta-galactosidase
from bovine testes. The use of oversaturated donor solutions (pNP beta Gal) enhanced the yields up to 60%. This method was verified using divalent structures as acceptors, that rendered di- and tri-galactosylated products. Further treatment of the disaccharides with CMP-Neu5Ac and alpha 2-3 sialyltransferase from pork liver led to formation of trisaccharides. Finally, mono-, di-, and trisaccharides were coupled to BSA employing a thiolic group introduced into the protein for Michael addition to a maleinimide group in the spacer-arm of the saccharide components. The results were monitored by HPLC and MALDI-TOF.
...
PMID:Chemoenzymatic synthesis of spacer-linked oligosaccharides for the preparation of neoglycoproteins. 1046 14
Interleukin-10 (IL-10) and interleukin-4 (IL-4), two Th2-derived cytokines, are molecules with anti-inflammatory and immunodeviating properties whose direct expression in allografts may prolong graft survival. Recombinant adenoviruses represent efficient vectors for gene transfer in quiescent cells in vivo. Adenoviral vectors encoding rat IL-10 (AdIL-10), rat IL-4 (AdIL-4) or
beta-galactosidase
(AdlacZ) or without transgene (Addl324) were injected directly into rat hearts at the time of transplantation in order to test their potential to prolong heart allograft survival. Expression of vectorized sequences was confirmed in heart biopsies, and kinetic analysis of
beta-galactosidase
showed transient expression. Cardiac allograft survival was significantly prolonged after administration of 10(9) p.f.u. of AdIL-10 (16.6 +/- 3.2 days, P < 0.05), but not AdIL-4 (9.8 +/- 1.6 days), compared with Addl324-treated (9.3 +/- 3.3 days) or untreated groups (7.8 +/- 1.5 days). Immunohistochemical analysis of allografts after gene transfer of IL-10 showed that leukocyte infiltration was quantitatively equivalent to that seen in control groups but with a strong tendency towards lower levels of CD8+ cells. Importantly, adenovirus-derived IL-10 modified the functional status of leukocytes by inducing a significant decrease in IFN-gamma production but significantly increased transforming-growth factor
beta 1
(TGF-beta 1) expression within the grafts compared with those treated with Addl324. These results show that expression of IL-10 by rat hearts after gene transfer mediated by an adenoviral vector decreases allogeneic immune responses and allows prolongation of allograft survival.
...
PMID:Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. 1075 24
The enzymatic synthesis of Gal-
beta 1
,3[GlcNAc-
beta 1
,6]-GalNAc-alpha 1-OBn (core 2-Bn) using a multi-enzyme system consisting of a
beta-galactosidase
(
EC 3.2.1.23
) from bovine testes and a recombinant core 2
beta 1
,6-GlcNAc transferase (C2GnT, EC 2.4.1.102) was empirically optimized by the use of a genetic algorithm. After variation of seven relevant parameters and performance of 56 experiments, two local maxima regarding the selection criteria could be found after four generations of optimization. The selectivity of core 2-Bn formation showed values up to 90%.
...
PMID:Optimization of the enzymatic synthesis of O-glycan core 2 structure by use of a genetic algorithm. 1190 10
<< Previous
1
2
3
4
5
6
7
8
9
10